Open original FDA record ↗Recall record
- FDA identifier
- Z-0254-2013
- Company in FDA record
- Sysmex America, Inc.
- FDA classification date
- Nov 6, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
There is a variation of reticulocyte counts between XE Series (XE-2100, XE-5000) and XT-Series (XT-2000i, XT-4000i) hematology analyzers that may result in a retic counts that are an average of 21% lower on the XE-Series because of a low bias.
Source facts
- Action
- Sysmex America, Inc. sent a "PRODUCT NOTIFICATION" letter dated May 2012 to all affected customers on June 1, 2012. The letter identifies the product, problem, and actions to be taken. The letter instructs customers to review patient results to determine if their Reference Intervals need adjustment, and to review QC results via Insight and document any change that may be linked to the date of calibration if appropriate. Any questions concerning the information contained in the notification were directed to the Sysmex Technical Assistance Center at 1-888-879-7639.
- Initiated
- 2012-06-01
- Root cause
- Device Design
- Terminated
- 2016-08-22
- Distribution
- Nationwide distribution: USA including Puerto Rico.
- Recall number
- Z-0254-2013
- Recall status
- Terminated
- CDRH record ID
- 111088
- FDA classified
- 2012-11-06
- Recall event number
- 62580